Response to Costantini et al. "Comments on Increased Response Rates to Salvage Chemotherapy Administered after PD-1/PD-L1 Inhibitors in Patients with Non-Small Cell Lung Cancer"

被引：1
|
作者：
Sun, Jong-Mu [1 ]
机构：
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, 81 Irwon Ro, Seoul 06351, South Korea
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 04期
关键词：
GEMCITABINE; CISPLATIN;
D O I：
10.1016/j.jtho.2017.11.122
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E56 / E57
页数：3
相关论文
共 50 条
  • [1] Increased Response Rates to Salvage Chemotherapy Administered after PD-1/PD-L1 Inhibitors in Patients with Non-Small Cell Lung Cancer
    Park, Song Ee
    Lee, Se Hoon
    Ahn, Jin Seok
    Ahn, Myung-Ju
    Park, Keunchil
    Sun, Jong-Mu
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (01) : 106 - 111
  • [2] Increased Response Rates to Salvage Chemotherapy Administered after PD-1/PD-L1 Inhibitors in Patients with Non-Small Cell Lung Cancer
    Costantini, Adrien
    Cadranel, Jacques
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : E55 - E56
  • [3] Increased Antitumor Response to Chemotherapy Administered after PD-1/PD-L1 Inhibitors in Patients with Non-Small Cell Lung Cancer
    Park, S. E.
    Kim, Y.
    Kim, H. K.
    Lee, H.
    Cho, J. H.
    Lim, S. W.
    Lee, S.
    Ahn, J. S.
    Park, K.
    Ahn, M.
    Sun, J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2425 - S2425
  • [4] Response to Salvage Chemotherapy Following Exposure to PD-1 Inhibitors in Patients with Non-Small Cell Lung Cancer
    Leger, Paul
    Castellanos, Emily
    Pillai, Rathi
    Horn, Leora
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S918 - S919
  • [5] Predictive biomarkers of response to PD-1/PD-L1 immune checkpoint inhibitors in non-small cell lung cancer
    Shien, Kazuhiko
    Papadimitrakopoulou, Vassiliki A.
    Wistuba, Ignacio I.
    [J]. LUNG CANCER, 2016, 99 : 79 - 87
  • [6] Response to salvage chemotherapy following exposure to PD-1/PD-L1 inhibitors in patients with NSCLC
    Rothschild, S. I.
    Leger, P.
    Castellanos, E. L.
    Pillai, R. N.
    York, S. J.
    Horn, L.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [7] PD-1/PD-L1 inhibitors as a hope for smokers of non-small cell lung cancer patient
    Yu, Zhuo
    Zhang, Peiqing
    Gu, Weikuan
    Jiang, Xicheng
    [J]. TRANSLATIONAL CANCER RESEARCH, 2019, 8 (08) : 2941 - 2943
  • [8] Efficacy and safety of PD-1/PD-L1 inhibitors in elderly patients with advanced non-small cell lung cancer
    Li, Li
    Xu, Chunhua
    Wang, Wei
    Zhang, Qian
    [J]. CLINICAL RESPIRATORY JOURNAL, 2024, 18 (05):
  • [9] PD-1 and PD-L1 inhibitor toxicities in non-small cell lung cancer
    Shankar, Bairavi
    Naidoo, Jarushka
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 : S4034 - S4037
  • [10] Research progression of PD-1/PD-L1 in non-small cell lung cancer
    Xing Liu
    Xiaodong Xie
    [J]. Oncology and Translational Medicine, 2017, 3 (03) : 111 - 115
12345